SG Americas Securities’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-212,333
Closed -$401K 3527
2024
Q3
$401K Buy
212,333
+66,014
+45% +$3.01M ﹤0.01% 1885
2024
Q2
$182K Buy
146,319
+91,875
+169% +$4.03M ﹤0.01% 2215
2024
Q1
$125K Buy
54,444
+1,633
+3% +$74.4K ﹤0.01% 2375
2023
Q4
$96K Buy
52,811
+22,633
+75% +$963K ﹤0.01% 2781
2023
Q3
$82K Buy
+30,178
New +$1.41M ﹤0.01% 2845

Other funds holding QGEN

SG Americas Securities's QGEN Position: Q1 2026 in Review

SG Americas Securities opened a new position in Qiagen (QGEN) in Q1 2026: 96,848 shares worth $3.88M. The stake represents ﹤0.01% of the portfolio and ranks #1126 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in QGEN as recently as Q3 2025.

SG Americas Securities first reported a position in QGEN in Q1 2017 and has held it in 32 quarters since. The position peaked at $21.2M in Q3 2024. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • SG Americas Securities held 96,848 shares of Qiagen worth $3.88M as of Q1 2026.
  • Qiagen was a new SG Americas Securities position in Q1 2026.
  • Qiagen made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #1126 holding.
  • SG Americas Securities first reported a position in Qiagen in Q1 2017 and has held it in 32 quarters since.
  • SG Americas Securities's Qiagen position peaked at $21.2M in Q3 2024.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.